DATABASE
Home
Database
Who We Are
What We Offer
Register
Sign In
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Name
Category
Amarante SA
Company
Amaranth Advisors LLC
Company
Amaranth International Limited - Series 2 Designated Investment Shares
Fund
Amaranth International Limited - Series 2 Designated Investment Shares 9864 (DI2)
Fund
Amaranth International Limited - Shares Series 10158
Fund
Amaranth International Limited Series 9
Fund
Amaranth International Limited Series1
Fund
Amaranth International Limited Series1
Fund
Amaranth International Limited Shares Series 9864 DI1
Fund
Amaranth International Limited Shares Series 9942 DI1
Fund
Amarantus Announces Preclinical Development Timeline for MANF Therapeutic
News
Amarantus Appoints Russell Miller as Director of Investor Relations
News
AMARANTUS BIOSCIENCE HOLDINGS, INC. Files SEC form 10-K/A, Annual Report
News
AMARANTUS BIOSCIENCE HOLDINGS, INC. Files SEC form 10-Q, Quarterly Report
News
AMARANTUS BIOSCIENCE HOLDINGS, INC. Files SEC form 8-K, Other Events
News
AMARANTUS BIOSCIENCE HOLDINGS, INC. Financials
News
Amarantus BioScience President and CEO Publishes New Blog Entitled ''Continued Progress with our Business Plan in Central Nervous System Disorders''
News
Amarantus BioSciences Inc.
Fund
Amarantus LymPro Could Be A Game-Changer For Alzheimer's Diagnosis
News
Amarantus Posts LymPro Test® Alzheimer’s Diagnostic White Paper to Web Site
News
Amarantus Posts Review of MANF Literature to Web Site
News
Amarantus Provides Update on #C4CT Concussion Awareness Summit on June 21 in Minneapolis
News
Amarantus to Present at BIO Business Forum April 23rd
News
Amarantus to Present at the 2nd Annual Marcum MicroCap Conference on May 30
News
Amarc reports drill results from Gnat copper deposit, British Columbia - Surface exploration delineates new porphyry copper deposit targets at the Gal
News
Page 468 of 1100